Wilmington, Delaware, United States, Transparency Market Research Inc. , Feb. 14, 2025 (GLOBE NEWSWIRE) -- The global adrenoleukodystrophy drugs market (Markt für Medikamente gegen ...

DALLAS, Jan. 7, 2025 /PRNewswire/ -- The Hall family has established the "Will to Cure ALD" fund at The Dallas Foundation to support cutting-edge medical research through grants aimed at improving ...

Cerebral adrenoleukodystrophy is a severe form of X-linked adrenoleukodystrophy characterized by white-matter disease, loss of neurologic function, and early death. Elivaldogene autotemcel (eli-cel) ...

Adrenoleukodystrophy (ALD) is rare X-linked genetic disease that affects the adrenal glands (found on top of the kidneys) as well as the myelin in the brain and spinal cord. The incidence of ALD is ...

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic ...